NICE recommendations for drug coverage shown to have little impact

05/26/2004 | Financial Times (free content)

Pharmaceutical industry and related studies indicate the U.K.'s National Institute for Clinical Excellence, which recommends to the National Health Service which drugs to cover, has little impact on the introduction of new treatments. If the NICE recommendations had been adopted, according to studies by Roche, NICE and the Association of British Pharmaceutical Industry, they would have added millions to NHS drug coverage costs.

View Full Article in:

Financial Times (free content)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice President - Government Products
Health Alliance Plan
Detroit, MI
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Actuary
Meridian Health Plan
Detroit, MI
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
President/Chief Executive Officer
MedCost
Winston-Salem, NC